Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endoplasmic reticulum aminopeptidase 1 (ERAP1) is an intracellular zinc-dependent aminopeptidase enzyme primarily located in the endoplasmic reticulum. It plays a crucial role in antigen processing and presentation, particularly for MHC class I molecules, and in the regulation of cytokine receptors. Alterations in ERAP1 function have been linked to autoimmune diseases and cancer immunity, making it a potential target for therapeutic intervention.
Inhibition of ERAP1 activity, targeting either active or regulatory sites
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endoplasmic Reticulum Aminopeptidase 1.